Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03488108 · ClinicalTrials.gov registry record · Phase 1
Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT03488108: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT03488108 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03488108, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.
Interventions
- OTHER Platelet Rich Plasma
- DRUG Minoxidil Foam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-01-23 |
| Est. Completion | 2019-06-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03488108
The ClinicalTrials.gov registry entry for NCT03488108 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Platelet Rich Plasma is the first listed.
NCT03488108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03488108 about?
NCT03488108 is a clinical study titled "Platelet Rich Plasma Versus Minoxidil Foam for Treatment of Androgenic Alopecia in Women". The primary objective of this proposal is to conduct a study that assesses the safety, feasibility and efficacy of using PRP to treat this type of hair loss.
What is the current status of trial NCT03488108?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2017-01-23. Estimated completion is 2019-06-17.
What interventions are being tested in trial NCT03488108?
The interventions under investigation include: Platelet Rich Plasma (OTHER), Minoxidil Foam (DRUG).
Who is sponsoring clinical trial NCT03488108?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.